Vernet, Aurore
Meynard, Donaldo
Lian, Qichao http://orcid.org/0000-0003-0737-8332
Mieulet, Delphine
Gibert, Olivier http://orcid.org/0000-0002-1447-9003
Bissah, Matilda http://orcid.org/0000-0002-7709-3327
Rivallan, Ronan http://orcid.org/0000-0001-6990-1606
Autran, Daphné http://orcid.org/0000-0002-5227-8966
Leblanc, Olivier
Meunier, Anne Cécile
Frouin, Julien http://orcid.org/0000-0003-1591-0755
Taillebois, James
Shankle, Kyle
Khanday, Imtiyaz http://orcid.org/0000-0003-1460-3577
Mercier, Raphael http://orcid.org/0000-0001-6508-6608
Sundaresan, Venkatesan http://orcid.org/0000-0002-4670-0630
Guiderdoni, Emmanuel http://orcid.org/0000-0003-2760-2864
Article History
Received: 2 September 2022
Accepted: 18 December 2022
First Online: 27 December 2022
Competing interests
: INRAE, the former employer of R.M., holds patents on <i>MiMe</i> and its use to engineer apomixis. A provisional application for an US patent has been filed on October 3rd 2022 (# 63/412,667) by UC Davis, CIRAD and MPIPZ, with I.K., V.S., E.G., De.M., and R.M. as inventors. The remaining authors declare no competing interests.